ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target.

Cheng, Xuan; Zhao, Jian-Xiong; Dong, Feng; Cao, Xu-Chen

Cheng, Xuan; Zhao, Jian-Xiong; Dong, Feng; Cao, Xu-Chen.

Afiliación

Cheng X; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zhao JX; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Dong F; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Cao XC; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.

Front Oncol ; 11: 759577, 2021.

Article en En | MEDLINE | ID: mdl-34804958

Palabras clave

ARID1A; SWI/SNF complex; endocrine resistance; metastatic breast cancer; synthetic lethality; therapeutic targets

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google